Letko, Brosseau & Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
VPM
WP
Letko, Brosseau & Associates's ADNT Position: Q1 2026 in Review
Letko, Brosseau & Associates increased its Adient (ADNT) stake by 2.6% in Q1 2026, buying an estimated $912K and bringing the position to 1,617,406 shares worth $32.7M. The position accounts for 0.53% of the portfolio, ranked #55.
Letko, Brosseau & Associates first reported a position in ADNT in Q4 2016 and has held it in 26 quarters since. The position peaked at $81M in Q1 2021. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.
- Letko, Brosseau & Associates held 1,617,406 shares of Adient worth $32.7M as of Q1 2026.
- Letko, Brosseau & Associates bought 41,021 Adient shares in Q1 2026, an estimated $912K.
- Adient made up 0.53% of Letko, Brosseau & Associates's portfolio in Q1 2026, its #55 holding.
- Letko, Brosseau & Associates first reported a position in Adient in Q4 2016 and has held it in 26 quarters since.
- Letko, Brosseau & Associates's Adient position peaked at $81M in Q1 2021.
- 287 funds tracked by Wall St. Rank held Adient as of Q1 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.